← FDA DRUG APPROVALS

FDA ANDA · ANDA085075

AEROLATE III

Sponsor: FLEMING PHARMS

APPLICATION
ANDA085075
TYPE
ANDA
ORIGINAL APPROVAL
1986-11-24
LATEST ACTION
1990-10-18
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

AEROLATE IIIDiscontinued
THEOPHYLLINE 65MG · CAPSULE, EXTENDED RELEASE · ORAL
AEROLATE SRDiscontinued
THEOPHYLLINE 260MG · CAPSULE, EXTENDED RELEASE · ORAL
AEROLATE JRDiscontinued
THEOPHYLLINE 130MG · CAPSULE, EXTENDED RELEASE · ORAL

Approval history

1990-10-18Labeling · Supplement 4AP
1989-10-13Labeling · Supplement 2AP
1986-11-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →